BXPHARMA fundamentals
An in-depth look to BEXIMCO PHARMACEUTICALS LTD operating, investing, and financing activities
BXPHARMA free cash flow for Q3 24 is 1.74 B BDT. For 2023, BXPHARMA free cash flow was 3.68 B BDT and operating cash flow was 6.09 B BDT.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BDT
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM